600998 九州通
已收盘 07-10 15:00:00
资讯
新帖
简况
九州通（600998）披露为子公司提供担保的进展公告，7月10日股价上涨0.2%
证券之星 · 07-10 22:34
九州通（600998）披露为子公司提供担保的进展公告，7月10日股价上涨0.2%
AI赋能医院智慧升级，海尔生物携手九州通为新疆按下智慧医疗“加速键”
证券之星 · 07-08
AI赋能医院智慧升级，海尔生物携手九州通为新疆按下智慧医疗“加速键”
每周股票复盘：九州通（600998）Q2获9项专利含5项发明
证券之星 · 07-05
每周股票复盘：九州通（600998）Q2获9项专利含5项发明
九州通（600998）披露2026年第二季度子公司取得专利的公告，7月1日股价上涨0.64%
证券之星 · 07-01
九州通（600998）披露2026年第二季度子公司取得专利的公告，7月1日股价上涨0.64%
九州通（600998）披露投资设立肯尼亚子公司公告，6月29日股价上涨3.25%
证券之星 · 06-29
九州通（600998）披露投资设立肯尼亚子公司公告，6月29日股价上涨3.25%
每周股票复盘：九州通（600998）拟投200万美元设肯尼亚子公司
证券之星 · 06-28
每周股票复盘：九州通（600998）拟投200万美元设肯尼亚子公司
正海生物：目前公司海外业务与九州通暂无相关合作
证券之星 · 06-23
正海生物：目前公司海外业务与九州通暂无相关合作
每周股票复盘：九州通（600998）为32家子公司担保25.74亿元
证券之星 · 06-20
每周股票复盘：九州通（600998）为32家子公司担保25.74亿元
九州通（600998）披露为子公司提供担保的进展公告，6月16日股价下跌1.64%
证券之星 · 06-16
九州通（600998）披露为子公司提供担保的进展公告，6月16日股价下跌1.64%
九州通（600998）股东楚昌投资集团有限公司质押8500万股，占总股本1.69%
证券之星 · 06-10
九州通（600998）股东楚昌投资集团有限公司质押8500万股，占总股本1.69%
九州通(600998.SH)：子公司盐酸氮䓬斯汀获批上市
智通财经 · 06-02
九州通(600998.SH)：子公司盐酸氮䓬斯汀获批上市
九州通（600998）披露2025年度差异化权益分派方案，6月1日股价上涨2.08%
证券之星 · 06-01
九州通（600998）披露2025年度差异化权益分派方案，6月1日股价上涨2.08%
每周股票复盘：九州通（600998）子公司药品通过一致性评价
证券之星 · 05-31
每周股票复盘：九州通（600998）子公司药品通过一致性评价
九州通新提交“九州美学”、“未公开”等5件商标注册申请
证券之星 · 05-28
九州通新提交“九州美学”、“未公开”等5件商标注册申请
九州通（600998）披露子公司药品通过仿制药一致性评价公告，5月26日股价上涨0.63%
证券之星 · 05-26
九州通（600998）披露子公司药品通过仿制药一致性评价公告，5月26日股价上涨0.63%
九州通(600998.SH)子公司盐酸苯海索片通过仿制药一致性评价
智通财经 · 05-26
九州通(600998.SH)子公司盐酸苯海索片通过仿制药一致性评价
每周股票复盘：九州通（600998）担保总额达298.65亿占净资产104.59%
证券之星 · 05-24
每周股票复盘：九州通（600998）担保总额达298.65亿占净资产104.59%
九州通（600998）披露2025年年度股东会决议公告，5月21日股价下跌1.43%
证券之星 · 05-21
九州通（600998）披露2025年年度股东会决议公告，5月21日股价下跌1.43%
九州通（600998）披露为子公司提供担保的进展公告，5月20日股价下跌0.81%
证券之星 · 05-20
九州通（600998）披露为子公司提供担保的进展公告，5月20日股价下跌0.81%
九州通（600998）披露2025年年度股东会会议资料，5月14日股价下跌1.58%
证券之星 · 05-14
九州通（600998）披露2025年年度股东会会议资料，5月14日股价下跌1.58%
公司概况
公司名称：
九州通医药集团股份有限公司
所属行业：
批发业
上市日期：
2010-11-02
主营业务：
九州通医药集团股份有限公司的主营业务是医药流通、医药新零售、医药工业、医药CSO业务。公司的主要产品是数字化医药分销、供应链业务、总代品牌推广业务（CSO）、医药工业自产及OEM业务、新零售与万店加盟业务（C端）、医疗健康（C端）、技术增值服务、数字物流与供应链解决方案。公司先后荣获中国上市公司协会2024年度“上市公司投资者关系管理最佳实践奖”、证券时报“中国上市公司投资者关系管理天马奖”、中国证券报金牛奖“2024年度金牛上市公司分红回报奖”和“2024年度金牛最具价值投资奖”等荣誉。
发行价格：
13.00
{"stockData":{"symbol":"600998","market":"SH","secType":"STK","nameCN":"九州通","latestPrice":5.01,"timestamp":1783666801000,"preClose":5,"halted":0,"volume":30611093,"delay":0,"changeRate":0.002,"floatShares":5042000000,"shares":5042000000,"eps":0.4003,"marketStatus":"已收盘","change":0.01,"latestTime":"07-10 15:00:00","open":5,"high":5.03,"low":4.91,"amount":152000000,"amplitude":0.024,"askPrice":5.01,"askSize":5273,"bidPrice":5,"bidSize":1903,"shortable":0,"etf":0,"ttmEps":0.4003,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783906200000},"marketStatusCode":5,"adr":0,"adjPreClose":5,"symbolType":"stock","openAndCloseTimeList":[[1783647000000,1783654200000],[1783659600000,1783666800000]],"highLimit":5.5,"lowLimit":4.5,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":5042470234,"isCdr":false,"pbRate":0.92,"roa":"--","peRate":12.515613,"roe":"2.62%","epsLYR":0.44,"committee":-0.779256,"marketValue":25263000000,"turnoverRate":0.0061,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-07-13。","floatMarketCap":25263000000},"requestUrl":"/m/hq/s/600998/wiki","defaultTab":"wiki","newsList":[{"id":"2650136356","title":"九州通（600998）披露为子公司提供担保的进展公告，7月10日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650136356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650136356?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:34","pubTimestamp":1783694054,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，九州通报收于5.01元，较前一交易日上涨0.2%，最新总市值为252.63亿元。近日，九州通医药集团股份有限公司发布《关于为子公司提供担保的进展公告》。公告显示，公司为山东九州通医药有限公司、青岛九州通医药有限公司等44家子公司提供合计275,969.90万元的担保，其中为资产负债率超过70%的子公司担保179,529.90万元。截至2026年6月30日，公司对外担保总额为3,184,098.62万元，占最近一期经审计净资产的111.51%。公司未对控股股东提供担保，无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0146","BK0250","BK0196","BK0183","BK0097","600998","BK0039","BK0188","BK0012","BK0187","BK0028","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649998966","title":"AI赋能医院智慧升级，海尔生物携手九州通为新疆按下智慧医疗“加速键”","url":"https://stock-news.laohu8.com/highlight/detail?id=2649998966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649998966?lang=zh_cn&edition=full","pubTime":"2026-07-08 19:11","pubTimestamp":1783509078,"startTime":"0","endTime":"0","summary":"7月7日，青岛海尔生物医疗股份有限公司与新疆九州通医药有限公司达成战略合作。双方将围绕“智慧医疗、健康新疆”核心理念，依托海尔生物在AI与物联网领域的技术积累，共同构建覆盖乡村至城市的多层级智慧医疗体系，推动新疆医疗服务效率与疾病防控能力的整体提升。双方将以智慧医院、智慧疾控、智慧血液及智慧实验室四大场景为切入点，推动新疆医疗健康服务的数智化升级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026070800036799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0077","BK0251","BK0201","BK0188","600998","BK0028","BK0196","BK0146","BK0012","BK0187","BK0183","BK0039","688139","LU2488822045.USD","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649921776","title":"每周股票复盘：九州通（600998）Q2获9项专利含5项发明","url":"https://stock-news.laohu8.com/highlight/detail?id=2649921776","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649921776?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:11","pubTimestamp":1783195869,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，九州通报收于4.94元，较上周的4.62元上涨6.93%。本周关注点公司公告汇总：九州通2026年第二季度获9项专利，包括5项发明专利和4项实用新型专利。公司公告汇总：九州通将参加2026年7月9日举办的湖北辖区投资者集体接待日活动。截至2026年3月31日，公司及下属子公司累计获得专利权551项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0183","BK0097","BK0039","BK0146","BK0187","BK0201","BK0028","BK0196","600998","BK0077","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648541125","title":"九州通（600998）披露2026年第二季度子公司取得专利的公告，7月1日股价上涨0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648541125","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648541125?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:42","pubTimestamp":1782916938,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，九州通报收于4.72元，较前一交易日上涨0.64%，最新总市值为238亿元。该股当日开盘4.69元，最高4.75元，最低4.55元，成交额达1.6亿元，换手率为0.68%。近日，九州通医药集团股份有限公司披露《关于2026年第二季度子公司取得专利的公告》。公告显示，公司子公司于2026年第二季度共取得国家知识产权局颁发的9项专利，其中发明专利5项、实用新型专利4项。截至2026年3月31日，公司及下属子公司累计获得专利权551项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0201","BK0250","BK0077","BK0028","BK0097","BK0012","BK0146","BK0187","BK0183","600998","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647320746","title":"九州通（600998）披露投资设立肯尼亚子公司公告，6月29日股价上涨3.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647320746","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647320746?lang=zh_cn&edition=full","pubTime":"2026-06-29 17:51","pubTimestamp":1782726688,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，九州通报收于4.77元，较前一交易日上涨3.25%，最新总市值为240.53亿元。该股当日开盘4.59元，最高4.79元，最低4.48元，成交额达1.64亿元，换手率为0.69%。近日，九州通医药集团股份有限公司披露第六届董事会第二十次会议决议公告。公告显示，2026年6月26日，公司召开第六届董事会第二十次会议，审议通过《关于公司投资设立海外子公司的议案》。本次投资不构成关联交易，不构成重大资产重组，无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900028235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","BK0201","BK0039","BK0250","BK0146","BK0196","BK0077","BK0187","BK0012","BK0028","BK0097","BK0188","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646151313","title":"每周股票复盘：九州通（600998）拟投200万美元设肯尼亚子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2646151313","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646151313?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:24","pubTimestamp":1782584652,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，九州通报收于4.62元，较上周的4.83元下跌4.35%。本周关注点公司公告汇总：九州通拟使用200万美元自有资金在肯尼亚设立子公司。本次变动后，楚昌投资及其一致行动人合计持有公司股份2,290,962,492股，占总股本的45.43%，累计质押股份1,307,286,845股，占其所持股份的57.06%，占公司总股本的25.93%。董事会同意公司使用自有资金200万美元在肯尼亚投资设立子公司，开展医药供应链等业务，并授权管理层办理相关设立事宜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0097","BK0250","BK0028","600998","BK0188","BK0146","BK0012","BK0039","BK0201","BK0183","BK0077","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645886495","title":"正海生物：目前公司海外业务与九州通暂无相关合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2645886495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645886495?lang=zh_cn&edition=full","pubTime":"2026-06-23 15:45","pubTimestamp":1782200710,"startTime":"0","endTime":"0","summary":"证券之星消息，正海生物(300653)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：公司拓展海外业务的委托代理公司是否为九州通？正海生物回复：尊敬的投资者您好，感谢您的关注与支持！目前公司海外业务与九州通暂无相关合作。再次感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300022403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0187","BK0039","BK0250","BK0183","300653","BK0097","BK0146","BK0012","BK0196","BK0201","BK0251","BK0188","BK0028","BK0077","600998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644065063","title":"每周股票复盘：九州通（600998）为32家子公司担保25.74亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065063","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065063?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:17","pubTimestamp":1781896630,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，九州通报收于4.83元，较上周的4.79元上涨0.84%。本周，九州通6月15日盘中最高价报4.88元。本周关注点公司公告汇总：九州通为32家子公司提供合计257,400.00万元担保。截至2026年5月31日，公司对外担保总额为3,137,318.72万元，占最近一期经审计净资产的109.87%，无逾期担保。担保对象主要为控股子公司及其下属企业，公司拥有控制权，经营状况良好，担保风险可控。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000001953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0187","BK0146","BK0077","BK0012","BK0201","BK0188","600998","BK0250","BK0183","BK0039","BK0097","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643557737","title":"九州通（600998）披露为子公司提供担保的进展公告，6月16日股价下跌1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643557737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643557737?lang=zh_cn&edition=full","pubTime":"2026-06-16 18:23","pubTimestamp":1781605384,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，九州通报收于4.79元，较前一交易日下跌1.64%，最新总市值为241.53亿元。近日，九州通医药集团股份有限公司发布《关于为子公司提供担保的进展公告》。截至2026年5月31日，公司对外担保总额为3,137,318.72万元，占最近一期经审计净资产的109.87%，无逾期担保。担保对象主要为控股子公司及其下属企业，公司拥有控制权，经营状况良好，担保风险可控。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600033748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","600998","BK0183","BK0146","BK0012","BK0097","BK0028","BK0188","BK0250","BK0201","BK0196","BK0039","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428892","title":"九州通（600998）股东楚昌投资集团有限公司质押8500万股，占总股本1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428892","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642428892?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:43","pubTimestamp":1781088215,"startTime":"0","endTime":"0","summary":"证券之星消息，九州通6月10日公开信息显示，股东楚昌投资集团有限公司向平安银行股份有限公司武汉分行合计质押8500.0万股，占总股本1.69%。本文数据来源于九州通公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000035343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","BK0028","BK0196","BK0201","BK0183","BK0097","BK0250","BK0146","BK0012","BK0039","BK0188","BK0077","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986916","title":"九州通(600998.SH)：子公司盐酸氮䓬斯汀获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986916","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640986916?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:53","pubTimestamp":1780390421,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九州通(600998.SH)发布公告，公司控股子公司北京京丰制药(山东)有限公司于2026年6月1日收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》，批准盐酸氮䓬斯汀上市申请。据悉，盐酸氮䓬斯汀是一种选择性组胺H1受体拮抗剂，具有抗组胺及抗过敏作用，可阻止过敏反应中某些化学介质(如白三烯、组胺)的合成和释放，并能够抑制嗜酸性粒细胞的移行，发挥广泛抗炎作用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0187","BK0146","BK0028","BK0097","BK0183","BK0188","BK0196","BK0012","BK0250","IPOS","BK0201","BK0039","600998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640167950","title":"九州通（600998）披露2025年度差异化权益分派方案，6月1日股价上涨2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640167950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640167950?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:29","pubTimestamp":1780324158,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，九州通报收于4.9元，较前一交易日上涨2.08%，最新总市值为247.08亿元。公司拟以2025年度权益分派股权登记日总股本扣除回购专户股份为基数，向全体普通股股东每10股派发现金红利2.00元（含税），不进行资本公积转增股本。截至2026年5月20日，公司总股本为5,042,470,234股，回购专户持有56,036,500股，实际参与分配股份数为4,986,433,734股，合计派发现金红利997,286,746.80元。本次差异化权益分派对除权除息参考价格影响小于1%，符合相关监管规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600998","BK0201","BK0039","BK0250","BK0146","BK0196","BK0077","BK0187","BK0012","BK0028","BK0097","BK0188","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639604709","title":"每周股票复盘：九州通（600998）子公司药品通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2639604709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639604709?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:17","pubTimestamp":1780172229,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，九州通报收于4.8元，较上周的4.79元上涨0.21%。本周关注点公司公告汇总：子公司盐酸苯海索片通过仿制药一致性评价公司公告汇总：该药品2025年医院销售额为0.86亿元公司公告汇总：山东京丰已投入研发费用约685万元公司公告汇总九州通子公司北京京丰制药（山东）有限公司收到国家药品监督管理局核准签发的盐酸苯海索片《药品补充申请批准通知书》，批准该药品通过仿制药质量和疗效一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0039","BK0250","BK0028","BK0201","BK0187","BK0196","BK0183","600998","BK0012","BK0188","BK0077","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638634152","title":"九州通新提交“九州美学”、“未公开”等5件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2638634152","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638634152?lang=zh_cn&edition=full","pubTime":"2026-05-28 06:41","pubTimestamp":1779921687,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日九州通医药集团股份有限公司新提交“九州美学”、“未公开”等5件商标注册申请。商标申请详情如下：今年以来九州通医药集团股份有限公司新申请注册商标22件，截止目前公司共持有注册商标1244件，另有199件商标尚在注册申请中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800005323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0187","BK0077","BK0097","BK0183","BK0196","BK0146","BK0028","BK0188","BK0201","BK0250","BK0012","600998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638543757","title":"九州通（600998）披露子公司药品通过仿制药一致性评价公告，5月26日股价上涨0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638543757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638543757?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:45","pubTimestamp":1779806720,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，九州通报收于4.82元，较前一交易日上涨0.63%，最新总市值为243.05亿元。近日，九州通发布关于子公司药品通过仿制药一致性评价的公告。公告显示，九州通子公司北京京丰制药（山东）有限公司收到国家药品监督管理局核准签发的盐酸苯海索片《药品补充申请批准通知书》，批准该药品通过仿制药质量和疗效一致性评价。盐酸苯海索片为国家医保甲类品种，用于治疗帕金森病及药物引起的锥体外系反应。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0028","BK0187","BK0201","BK0077","BK0012","600998","BK0196","BK0097","BK0146","BK0188","BK0250","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638590901","title":"九州通(600998.SH)子公司盐酸苯海索片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2638590901","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638590901?lang=zh_cn&edition=full","pubTime":"2026-05-26 17:23","pubTimestamp":1779787410,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九州通(600998.SH)发布公告，近日，公司子公司北京京丰制药(山东)有限公司收到国家药品监督管理局核准签发的盐酸苯海索片《药品补充申请批准通知书》，批准盐酸苯海索片(2mg)通过仿制药质量和疗效一致性评价(简称“一致性评价”)。据悉，盐酸苯海索片是一种抗胆碱能药物，该药可选择性阻断纹状体的胆碱能神经通路，而对外周作用较小，从而有利于恢复帕金森病患者脑内多巴胺和乙酰胆碱的平衡，改善患者的帕金森病症状;对于抗精神病药等药物引发的锥体外系反应，本品也有良好疗效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","BK0201","600998","BK0183","BK0077","BK0097","BK0250","BK0188","BK0146","BK0028","BK0187","BK0039","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637730773","title":"每周股票复盘：九州通（600998）担保总额达298.65亿占净资产104.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637730773","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637730773?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:10","pubTimestamp":1779563422,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，九州通报收于4.79元，较上周的4.95元下跌3.23%。本周，九州通5月18日盘中最高价报4.94元。截至2026年4月30日，公司对外担保总额为2,986,518.62万元，占最近一期经审计净资产的104.59%，其中对资产负债率超过70%的子公司提供担保152,550.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0012","BK0250","BK0183","BK0188","BK0187","BK0028","BK0039","BK0196","BK0097","BK0146","600998","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375563","title":"九州通（600998）披露2025年年度股东会决议公告，5月21日股价下跌1.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375563","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637375563?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:51","pubTimestamp":1779375072,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，九州通报收于4.81元，较前一交易日下跌1.43%，最新总市值为242.54亿元。近日，九州通医药集团股份有限公司披露《2025年年度股东会决议公告》。公告显示，公司于2026年5月21日召开2025年年度股东会，审议通过了2025年度董事会工作报告、年度报告及摘要、独立董事述职报告、利润分配预案、董事薪酬议案、续聘中审众环会计师事务所为2026年审计机构、修订部分管理制度等议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0012","600998","BK0188","BK0250","BK0077","BK0187","BK0146","BK0201","BK0028","BK0039","BK0196","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636725845","title":"九州通（600998）披露为子公司提供担保的进展公告，5月20日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636725845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636725845?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:30","pubTimestamp":1779273038,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，九州通报收于4.88元，较前一交易日下跌0.81%，最新总市值为246.07亿元。九州通于2026年5月20日发布《关于为子公司提供担保的进展公告》。公告显示，公司为河南九州通医药有限公司、山东九州通医药有限公司等49家子公司提供合计292,050.00万元的担保，均为前期预计额度内的担保，且部分担保设有反担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0039","BK0250","BK0028","BK0201","BK0187","BK0196","BK0183","600998","BK0012","BK0188","BK0077","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635274745","title":"九州通（600998）披露2025年年度股东会会议资料，5月14日股价下跌1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635274745","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635274745?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:31","pubTimestamp":1778769073,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，九州通报收于4.99元，较前一交易日下跌1.58%，最新总市值为251.62亿元。该股当日开盘5.06元，最高5.07元，最低4.97元，成交额达1.69亿元，换手率为0.67%。近日，九州通医药集团股份有限公司披露《2025年年度股东会会议资料》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0201","BK0028","BK0188","600998","BK0183","BK0077","BK0187","BK0250","BK0039","BK0146","BK0012","BK0196"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783772951536,"stockEarnings":[{"period":"1week","weight":0.0142},{"period":"1month","weight":0.0614},{"period":"3month","weight":-0.0266},{"period":"6month","weight":-0.0138},{"period":"1year","weight":-0.0194},{"period":"ytd","weight":0.0191}],"compareEarnings":[{"period":"1week","weight":-0.0117},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.0025},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.1386},{"period":"ytd","weight":0.0069}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"九州通医药集团股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"58392人(较上一季度增加13.92%)","perCapita":"86355股","listingDate":"2010-11-02","address":"湖北省武汉市汉阳区龙兴西街5号","registeredCapital":"504247万元","survey":" 九州通医药集团股份有限公司的主营业务是医药流通、医药新零售、医药工业、医药CSO业务。公司的主要产品是数字化医药分销、供应链业务、总代品牌推广业务（CSO）、医药工业自产及OEM业务、新零售与万店加盟业务（C端）、医疗健康（C端）、技术增值服务、数字物流与供应链解决方案。公司先后荣获中国上市公司协会2024年度“上市公司投资者关系管理最佳实践奖”、证券时报“中国上市公司投资者关系管理天马奖”、中国证券报金牛奖“2024年度金牛上市公司分红回报奖”和“2024年度金牛最具价值投资奖”等荣誉。","listedPrice":13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九州通,600998,九州通股票,九州通股票老虎,九州通股票老虎国际,九州通行情,九州通股票行情,九州通股价,九州通股市,九州通股票价格,九州通股票交易,九州通股票购买,九州通股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九州通(600998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九州通(600998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}